{"id":"tp-32781","type":"article-newspaper","title":"EU Medicines Panel Issues Positive Opinion on Revolution Medicines’ Rasonque","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/32781","datePublished":"2026-10-15T21:29:19.000Z","dateModified":"2026-10-15T21:29:19.000Z","language":"en","abstract":"The opinion covers second-line monotherapy for adults with metastatic pancreatic adenocarcinoma and was supported by Phase 3 study data.","section":"Business","references":[]}